Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
11,380
+504
+5% +$13.2K 0.23% 84
2026
Q1
$305K Sell
10,876
-37
-0.3% -$985 0.3% 63
2025
Q4
$272K Buy
10,913
+396
+4% +$9.99K 0.28% 73
2025
Q3
$268K Buy
10,517
+271
+3% +$6.69K 0.28% 66
2025
Q2
$248K Buy
10,246
+503
+5% +$11.7K 0.29% 66
2025
Q1
$247K Sell
9,743
-648
-6% -$17K 0.3% 67
2024
Q4
$276K Buy
10,391
+1,575
+18% +$42.7K 0.34% 60
2024
Q3
$255K Buy
8,816
+408
+5% +$11.9K 0.26% 70
2024
Q2
$235K Buy
8,408
+162
+2% +$4.46K 0.24% 76
2024
Q1
$229K Buy
+8,246
New +$229K 0.13% 106
2023
Q4
Sell
-6,803
Closed -$214K 103
2023
Q3
$214K Buy
6,803
+727
+12% +$25.7K 0.15% 94
2023
Q2
$220K Buy
+6,076
New +$236K 0.15% 88
2022
Q3
Sell
-4,179
Closed -$216K 86
2022
Q2
$216K Buy
4,179
+24
+0.6% +$1.22K 0.18% 77
2022
Q1
$207K Buy
4,155
+20
+0.5% +$1.04K 0.16% 77
2021
Q4
$206K Buy
+4,135
New +$205K 0.16% 80

Other funds holding PFE

ETF Store's PFE Position: Q2 2026 in Review

ETF Store increased its Pfizer (PFE) stake by 4.6% in Q2 2026, buying an estimated $13.2K and bringing the position to 11,380 shares worth $274K. The position accounts for 0.23% of the portfolio, ranked #84.

ETF Store first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. The position peaked at $305K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ETF Store held 11,380 shares of Pfizer worth $274K as of Q2 2026.
  • ETF Store bought 504 Pfizer shares in Q2 2026, an estimated $13.2K.
  • Pfizer made up 0.23% of ETF Store's portfolio in Q2 2026, its #84 holding.
  • ETF Store first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
  • ETF Store's Pfizer position peaked at $305K in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ETF Store's 13F filing for Q2 2026, filed 29 Jul 2026.